1. Show article details.

    Exosite Licenses IoT Technology to West Pharmaceutical Services, Inc.

    Business Wire – 8:55 AM ET 06/02/2020

    West will utilize Exosite software and solutions to accelerate its digital transformation initiatives in the healthcare marketplace Exosite LLC, a leading provider in the Industrial Internet of Things market, today announced that it has licensed use of certain software technology and solutions to West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug adm...

  2. Show article details.

    BRIEF-West Pharmaceutical Services To Join S&P 500 Index

    Reuters – 6:13 AM ET 05/21/2020

    West Pharmaceutical Services Inc (WST): * WEST PHARMACEUTICAL SERVICES, INC. TO JOIN S&P 500 INDEX Source text for Eikon: Further company coverage:

  3. Show article details.

    West Pharmaceutical Services, Inc. to Join S&P 500 Index

    PR Newswire – 6:00 AM ET 05/21/2020

    EXTON, Pa., May 21, 2020  West Pharmaceutical Services, Inc. , a global leader in innovative solutions for injectable drug administration, announced that it has been named to the S&P® 500, which will become effective after close of trading today.

  4. Show article details.

    West Pharmaceutical Services Set to Join S&P 500; Physicians Realty Trust to Join S&P MidCap 400; Helmerich & Payne to Join S&P SmallCap 600

    PR Newswire – 7:30 PM ET 05/18/2020

    NEW YORK, May 18, 2020  S&P Dow Jones Indices will make the following changes to the S&P 500, the S&P MidCap 400 and S&P SmallCap 600 effective prior to the open of trading on Friday, May 22: West Pharmaceutical Services manufactures and sells containment and delivery systems for injectable drugs and healthcare products. Headquartered in Exton, PA, the company will be added to the S&P 500 GICS ...

  5. Show article details.

    West to Participate in Upcoming Investor Conferences

    PR Newswire – 6:00 AM ET 05/07/2020

    EXTON, Pa., May 7, 2020 West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced it will participate in the Bank of America Securities 2020 Healthcare Conference on Thursday, May 14, 2020, as well as the Jeffries Virtual Healthcare Conference 2020 on Tuesday, June 2, 2020.

  6. Show article details.

    BRIEF-West Pharmaceutical Services Says Q1 Adjusted Earnings Per Share $1.01

    Reuters – 6:03 AM ET 04/23/2020

    West Pharmaceutical Services Inc (WST) : * WEST ANNOUNCES FIRST-QUARTER 2020 RESULTS. * SEES FY 2020 ADJUSTED EARNINGS PER SHARE $3.52 TO $3.62. * Q1 ADJUSTED EARNINGS PER SHARE $1.01. * Q1 EARNINGS PER SHARE $0.99. * Q1 EARNINGS PER SHARE ESTIMATE $0.82 -- REFINITIV IBES DATA. * SEES FY 2020 SALES $1.95 BILLION TO $1.97 BILLION.

  7. Show article details.

    West Announces First-Quarter 2020 Results

    PR Newswire – 6:00 AM ET 04/23/2020

    EXTON, Pa., April 23, 2020 West Pharmaceutical Services, Inc. (WST) today announced its financial results for the first-quarter 2020 and updated full-year 2020 financial guidance. First-Quarter 2020 Summary "Adjusted-diluted EPS" and "organic sales growth" are Non-U.S. GAAP measurements.

  8. Show article details.

    West to Host Virtual Shareholders Meeting

    PR Newswire – 6:00 AM ET 04/20/2020

    EXTON, Pa., April 20, 2020 West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that it is in the best interests of shareholders to hold a virtual shareholder meeting due to the ongoing COVID-19 pandemic and restrictions issued by the Commonwealth of Pennsylvania and the Center for Disease Control.

  9. Show article details.

    West to Host First-Quarter 2020 Conference Call

    PR Newswire – 6:00 AM ET 04/09/2020

    EXTON, Pa., April 9, 2020  West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2020 financial results before the market opens on Thursday, April 23, 2020, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.

Page:

Today's and Upcoming Events

  • Jul
    23

    WST to announce Q2 earnings (Unconfirmed)

Past Events (last 90 days)

  • Apr
    23

    WST announced Q1 earnings.

  • Apr
    21

    WST ex-Dividend for $0.16 on 04/21/2020

    • Announce Date: 02/25/2020
    • Record Date: 04/22/2020
    • Pay Date: 05/06/2020
Data provided by Thomson Reuters © 2020

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.